Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 617 entries
Sorted by: Best Match Show Resources per page
Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma.

Case reports in oncology

Fukushima T, Tateishi K, Hanaoka M, Koiwai K, Sasaki S, Koizumi T.
PMID: 24575019
Case Rep Oncol. 2014 Jan 24;7(1):65-9. doi: 10.1159/000358380. eCollection 2014 Jan.

Little information is available about the usefulness of concurrent chemoradiotherapy for locally advanced thymic carcinoma due to a rare anterior mediastinal tumor. We experienced a case of locally advanced thymic carcinoma that responded well to concurrent thoracic radiotherapy combined...

Cite
Fukushima T, Tateishi K, Hanaoka M, et al. Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma. Case Rep Oncol. 2014;7(1):65-9doi: 10.1159/000358380.
Fukushima, T., Tateishi, K., Hanaoka, M., Koiwai, K., Sasaki, S., & Koizumi, T. (2014). Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma. Case reports in oncology, 7(1), 65-9. https://doi.org/10.1159/000358380
Fukushima, Toshirou, et al. "Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma." Case reports in oncology vol. 7,1 (2014): 65-9. doi: https://doi.org/10.1159/000358380
Fukushima T, Tateishi K, Hanaoka M, Koiwai K, Sasaki S, Koizumi T. Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma. Case Rep Oncol. 2014 Jan 24;7(1):65-9. doi: 10.1159/000358380. eCollection 2014 Jan. PMID: 24575019; PMCID: PMC3934680.
Copy Download .nbib Format: NLM
Postoperative surveillance with monthly serum tumor markers after living-donor liver transplantation for hepatocellular carcinoma.

Hepatology research : the official journal of the Japan Society of Hepatology

Yamashiki N, Sugawara Y, Tamura S, Tateishi R, Yoshida H, Kaneko J, Matsui Y, Togashi J, Akahane M, Makuuchi M, Omata M, Kokudo N.
PMID: 20070400
Hepatol Res. 2010 Apr;40(4):278-86. doi: 10.1111/j.1872-034X.2009.00591.x. Epub 2010 Jan 11.

AIM: Recurrence of hepatocellular carcinoma (HCC) after liver transplantation decreases patient survival. The usefulness of post-transplant surveillance with tumor markers, however, is not clear. We evaluated our cumulative experience with recurrent HCC detected during post-transplant surveillance.METHODS: We analyzed 100...

Cite
Yamashiki N, Sugawara Y, Tamura S, et al. Postoperative surveillance with monthly serum tumor markers after living-donor liver transplantation for hepatocellular carcinoma. Hepatol Res. 2010;40(4):278-86doi: 10.1111/j.1872-034X.2009.00591.x.
Yamashiki, N., Sugawara, Y., Tamura, S., Tateishi, R., Yoshida, H., Kaneko, J., Matsui, Y., Togashi, J., Akahane, M., Makuuchi, M., Omata, M., & Kokudo, N. (2010). Postoperative surveillance with monthly serum tumor markers after living-donor liver transplantation for hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology, 40(4), 278-86. https://doi.org/10.1111/j.1872-034X.2009.00591.x
Yamashiki, Noriyo, et al. "Postoperative surveillance with monthly serum tumor markers after living-donor liver transplantation for hepatocellular carcinoma." Hepatology research : the official journal of the Japan Society of Hepatology vol. 40,4 (2010): 278-86. doi: https://doi.org/10.1111/j.1872-034X.2009.00591.x
Yamashiki N, Sugawara Y, Tamura S, Tateishi R, Yoshida H, Kaneko J, Matsui Y, Togashi J, Akahane M, Makuuchi M, Omata M, Kokudo N. Postoperative surveillance with monthly serum tumor markers after living-donor liver transplantation for hepatocellular carcinoma. Hepatol Res. 2010 Apr;40(4):278-86. doi: 10.1111/j.1872-034X.2009.00591.x. Epub 2010 Jan 11. PMID: 20070400.
Copy Download .nbib Format: NLM
Isolation and characterization of microsatellite markers for Canavalia cathartica and C. lineata (Fabaceae).

Applications in plant sciences

Yamashiro A, Yamashiro T, Tateishi Y.
PMID: 25202474
Appl Plant Sci. 2013 Jan 02;1(1). doi: 10.3732/apps.1200111. eCollection 2013 Jan.

PREMISE OF THE STUDY: Microsatellite markers were developed for the sea-dispersed legume Canavalia cathartica to investigate its genetic diversity and population structure. We also applied these microsatellite markers to the closely related species C. lineata. •METHODS AND RESULTS: Ten...

Cite
Yamashiro A, Yamashiro T, Tateishi Y. Isolation and characterization of microsatellite markers for Canavalia cathartica and C. lineata (Fabaceae). Appl Plant Sci. 2013;1(1)doi: 10.3732/apps.1200111.
Yamashiro, A., Yamashiro, T., & Tateishi, Y. (2013). Isolation and characterization of microsatellite markers for Canavalia cathartica and C. lineata (Fabaceae). Applications in plant sciences, 1(1), . https://doi.org/10.3732/apps.1200111
Yamashiro, Asuka, et al. "Isolation and characterization of microsatellite markers for Canavalia cathartica and C. lineata (Fabaceae)." Applications in plant sciences vol. 1,1 (2013). doi: https://doi.org/10.3732/apps.1200111
Yamashiro A, Yamashiro T, Tateishi Y. Isolation and characterization of microsatellite markers for Canavalia cathartica and C. lineata (Fabaceae). Appl Plant Sci. 2013 Jan 02;1(1). doi: 10.3732/apps.1200111. eCollection 2013 Jan. PMID: 25202474; PMCID: PMC4105347.
Copy Download .nbib Format: NLM
Slight elevation of high-sensitivity C-reactive protein to predict recurrence and survival in patients with early stage hepatitis C-related hepatocellular carcinoma.

Hepatology research : the official journal of the Japan Society of Hepatology

Fujiwara N, Tateishi R, Nakagawa H, Nakagomi R, Kondo M, Minami T, Sato M, Uchino K, Enooku K, Kondo Y, Asaoka Y, Shiina S, Yoshida H, Koike K.
PMID: 25070147
Hepatol Res. 2015 Jun;45(6):645-55. doi: 10.1111/hepr.12398. Epub 2014 Sep 02.

AIM: Hepatocellular carcinoma (HCC) is associated with chronic inflammation derived from various origins. We investigated whether high-sensitivity C-reactive protein (hsCRP) could predict recurrence and survival after curative treatment for early stage hepatitis C virus-related HCC (C-HCC).METHODS: We enrolled 387...

Cite
Fujiwara N, Tateishi R, Nakagawa H, et al. Slight elevation of high-sensitivity C-reactive protein to predict recurrence and survival in patients with early stage hepatitis C-related hepatocellular carcinoma. Hepatol Res. 2014;45(6):645-55doi: 10.1111/hepr.12398.
Fujiwara, N., Tateishi, R., Nakagawa, H., Nakagomi, R., Kondo, M., Minami, T., Sato, M., Uchino, K., Enooku, K., Kondo, Y., Asaoka, Y., Shiina, S., Yoshida, H., & Koike, K. (2015). Slight elevation of high-sensitivity C-reactive protein to predict recurrence and survival in patients with early stage hepatitis C-related hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology, 45(6), 645-55. https://doi.org/10.1111/hepr.12398
Fujiwara, Naoto, et al. "Slight elevation of high-sensitivity C-reactive protein to predict recurrence and survival in patients with early stage hepatitis C-related hepatocellular carcinoma." Hepatology research : the official journal of the Japan Society of Hepatology vol. 45,6 (2015): 645-55. doi: https://doi.org/10.1111/hepr.12398
Fujiwara N, Tateishi R, Nakagawa H, Nakagomi R, Kondo M, Minami T, Sato M, Uchino K, Enooku K, Kondo Y, Asaoka Y, Shiina S, Yoshida H, Koike K. Slight elevation of high-sensitivity C-reactive protein to predict recurrence and survival in patients with early stage hepatitis C-related hepatocellular carcinoma. Hepatol Res. 2015 Jun;45(6):645-55. doi: 10.1111/hepr.12398. Epub 2014 Sep 02. PMID: 25070147.
Copy Download .nbib Format: NLM
Whole-Genome Sequence of the Potentially Hypertransmissible Multidrug-Resistant Mycobacterium tuberculosis Beijing Strain OM-V02_005.

Genome announcements

Tateishi Y, Tamaru A, Ogura Y, Niki M, Wada T, Yamamoto T, Hirata K, Hayashi T, Matsumoto S.
PMID: 23929492
Genome Announc. 2013 Aug 08;1(4). doi: 10.1128/genomeA.00608-13.

We report the draft genome sequence of Mycobacterium tuberculosis Beijing strain OM-V02_005, which exhibits possible hypertransmissible characteristics among the population of patients with multidrug-resistant tuberculosis in Osaka Prefecture, the largest urban area in western Japan.

Cite
Tateishi Y, Tamaru A, Ogura Y, et al. Whole-Genome Sequence of the Potentially Hypertransmissible Multidrug-Resistant Mycobacterium tuberculosis Beijing Strain OM-V02_005. Genome Announc. 2013;1(4)doi: 10.1128/genomeA.00608-13.
Tateishi, Y., Tamaru, A., Ogura, Y., Niki, M., Wada, T., Yamamoto, T., Hirata, K., Hayashi, T., & Matsumoto, S. (2013). Whole-Genome Sequence of the Potentially Hypertransmissible Multidrug-Resistant Mycobacterium tuberculosis Beijing Strain OM-V02_005. Genome announcements, 1(4), . https://doi.org/10.1128/genomeA.00608-13
Tateishi, Yoshitaka, et al. "Whole-Genome Sequence of the Potentially Hypertransmissible Multidrug-Resistant Mycobacterium tuberculosis Beijing Strain OM-V02_005." Genome announcements vol. 1,4 (2013). doi: https://doi.org/10.1128/genomeA.00608-13
Tateishi Y, Tamaru A, Ogura Y, Niki M, Wada T, Yamamoto T, Hirata K, Hayashi T, Matsumoto S. Whole-Genome Sequence of the Potentially Hypertransmissible Multidrug-Resistant Mycobacterium tuberculosis Beijing Strain OM-V02_005. Genome Announc. 2013 Aug 08;1(4). doi: 10.1128/genomeA.00608-13. PMID: 23929492; PMCID: PMC3738908.
Copy Download .nbib Format: NLM
Octreotide acetate enables the administration of chemoradiotherapy, including the oral anticancer drug S-1, in gastric cancer patients with malignant gastrointestinal obstruction.

Oncology letters

Takahashi T, Saikawa Y, Igarashi T, Tsuwano S, Kumagai K, Nakamura R, Ooyama T, Wada N, Takeuchi H, Takaishi H, Kitagawa Y.
PMID: 22966362
Oncol Lett. 2010 Jul;1(4):673-677. doi: 10.3892/ol_00000118. Epub 2010 Jul 01.

Advanced gastric cancer frequently results in the inability to ingest food or drink orally, a condition called malignant gastrointestinal obstruction (MGO). MGO is clinically defined as a gastrointestinal outlet obstruction caused by a large tumor, or malignant bowel obstruction...

Cite
Takahashi T, Saikawa Y, Igarashi T, et al. Octreotide acetate enables the administration of chemoradiotherapy, including the oral anticancer drug S-1, in gastric cancer patients with malignant gastrointestinal obstruction. Oncol Lett. 2010;1(4):673-677doi: 10.3892/ol_00000118.
Takahashi, T., Saikawa, Y., Igarashi, T., Tsuwano, S., Kumagai, K., Nakamura, R., Ooyama, T., Wada, N., Takeuchi, H., Takaishi, H., & Kitagawa, Y. (2010). Octreotide acetate enables the administration of chemoradiotherapy, including the oral anticancer drug S-1, in gastric cancer patients with malignant gastrointestinal obstruction. Oncology letters, 1(4), 673-677. https://doi.org/10.3892/ol_00000118
Takahashi, Tsunehiro, et al. "Octreotide acetate enables the administration of chemoradiotherapy, including the oral anticancer drug S-1, in gastric cancer patients with malignant gastrointestinal obstruction." Oncology letters vol. 1,4 (2010): 673-677. doi: https://doi.org/10.3892/ol_00000118
Takahashi T, Saikawa Y, Igarashi T, Tsuwano S, Kumagai K, Nakamura R, Ooyama T, Wada N, Takeuchi H, Takaishi H, Kitagawa Y. Octreotide acetate enables the administration of chemoradiotherapy, including the oral anticancer drug S-1, in gastric cancer patients with malignant gastrointestinal obstruction. Oncol Lett. 2010 Jul;1(4):673-677. doi: 10.3892/ol_00000118. Epub 2010 Jul 01. PMID: 22966362; PMCID: PMC3436260.
Copy Download .nbib Format: NLM
Role of bypass surgery and balloon occlusion test for the endovascular management of fusiform dissecting aneurysms. Report of two cases.

Acta neurochirurgica. Supplement

Tanaka M, Maekawa H, Sakata Y, Obikane Y, Hadeishi H, Yamazaki A.
PMID: 24728631
Acta Neurochir Suppl. 2014;119:43-8. doi: 10.1007/978-3-319-02411-0_7.

Fusiform intracranial aneurysm is one of the most difficult pathologies to treat. The role and efficacy of recent advanced endovascular technique and conventional bypass surgery are discussed.

Cite
Tanaka M, Maekawa H, Sakata Y, et al. Role of bypass surgery and balloon occlusion test for the endovascular management of fusiform dissecting aneurysms. Report of two cases. Acta Neurochir Suppl. 2014;119:43-8doi: 10.1007/978-3-319-02411-0_7.
Tanaka, M., Maekawa, H., Sakata, Y., Obikane, Y., Hadeishi, H., & Yamazaki, A. (2014). Role of bypass surgery and balloon occlusion test for the endovascular management of fusiform dissecting aneurysms. Report of two cases. Acta neurochirurgica. Supplement, 11943-8. https://doi.org/10.1007/978-3-319-02411-0_7
Tanaka, Michihiro, et al. "Role of bypass surgery and balloon occlusion test for the endovascular management of fusiform dissecting aneurysms. Report of two cases." Acta neurochirurgica. Supplement vol. 119 (2014): 43-8. doi: https://doi.org/10.1007/978-3-319-02411-0_7
Tanaka M, Maekawa H, Sakata Y, Obikane Y, Hadeishi H, Yamazaki A. Role of bypass surgery and balloon occlusion test for the endovascular management of fusiform dissecting aneurysms. Report of two cases. Acta Neurochir Suppl. 2014;119:43-8. doi: 10.1007/978-3-319-02411-0_7. PMID: 24728631.
Copy Download .nbib Format: NLM
Very late stent thrombosis and neointimal plaque rupture after implantation of sirolimus-eluting stents: observations with angiography, IVUS and OCT.

Cardiovascular intervention and therapeutics

Sakamoto N, Nakazato K, Misaka T, Mizukami H, Kunii H, Suzuki H, Saitoh S, Takeishi Y.
PMID: 24122594
Cardiovasc Interv Ther. 2011 Sep;26(3):263-8. doi: 10.1007/s12928-011-0064-1. Epub 2011 Apr 28.

Drug-eluting stent (DES) dramatically reduces the incidence of restenosis and rates of target lesion revascularization. Although several reports suggest that very late stent thrombosis could occur in patients after DES implantation, neointimal plaque rupture may be uncommon in the...

Cite
Sakamoto N, Nakazato K, Misaka T, et al. Very late stent thrombosis and neointimal plaque rupture after implantation of sirolimus-eluting stents: observations with angiography, IVUS and OCT. Cardiovasc Interv Ther. 2011;26(3):263-8doi: 10.1007/s12928-011-0064-1.
Sakamoto, N., Nakazato, K., Misaka, T., Mizukami, H., Kunii, H., Suzuki, H., Saitoh, S., & Takeishi, Y. (2011). Very late stent thrombosis and neointimal plaque rupture after implantation of sirolimus-eluting stents: observations with angiography, IVUS and OCT. Cardiovascular intervention and therapeutics, 26(3), 263-8. https://doi.org/10.1007/s12928-011-0064-1
Sakamoto, Nobuo, et al. "Very late stent thrombosis and neointimal plaque rupture after implantation of sirolimus-eluting stents: observations with angiography, IVUS and OCT." Cardiovascular intervention and therapeutics vol. 26,3 (2011): 263-8. doi: https://doi.org/10.1007/s12928-011-0064-1
Sakamoto N, Nakazato K, Misaka T, Mizukami H, Kunii H, Suzuki H, Saitoh S, Takeishi Y. Very late stent thrombosis and neointimal plaque rupture after implantation of sirolimus-eluting stents: observations with angiography, IVUS and OCT. Cardiovasc Interv Ther. 2011 Sep;26(3):263-8. doi: 10.1007/s12928-011-0064-1. Epub 2011 Apr 28. PMID: 24122594.
Copy Download .nbib Format: NLM
Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.

Hepatology research : the official journal of the Japan Society of Hepatology

Sato M, Kato N, Tateishi R, Muroyama R, Kowatari N, Li W, Goto K, Otsuka M, Shiina S, Yoshida H, Omata M, Koike K.
PMID: 24125181
Hepatol Res. 2014 Oct;44(10):E137-44. doi: 10.1111/hepr.12258. Epub 2014 Jan 08.

AIM: The PNPLA3 rs738409 C>G polymorphism (encoding for I148M) has recently been identified as a susceptibility factor for steatosis-mediated liver damage. We evaluated the influence of this polymorphism on hepatocarcinogenesis in patients with chronic hepatitis C (CHC) virus infection.METHODS:...

Cite
Sato M, Kato N, Tateishi R, et al. Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Hepatol Res. 2014;44(10):E137-44doi: 10.1111/hepr.12258.
Sato, M., Kato, N., Tateishi, R., Muroyama, R., Kowatari, N., Li, W., Goto, K., Otsuka, M., Shiina, S., Yoshida, H., Omata, M., & Koike, K. (2014). Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Hepatology research : the official journal of the Japan Society of Hepatology, 44(10), E137-44. https://doi.org/10.1111/hepr.12258
Sato, Masaya, et al. "Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection." Hepatology research : the official journal of the Japan Society of Hepatology vol. 44,10 (2014): E137-44. doi: https://doi.org/10.1111/hepr.12258
Sato M, Kato N, Tateishi R, Muroyama R, Kowatari N, Li W, Goto K, Otsuka M, Shiina S, Yoshida H, Omata M, Koike K. Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Hepatol Res. 2014 Oct;44(10):E137-44. doi: 10.1111/hepr.12258. Epub 2014 Jan 08. PMID: 24125181.
Copy Download .nbib Format: NLM
Feedback function for capillary refilling time measurement device.

Critical care (London, England)

Shinozaki M, Nakada TA, Kawaguchi R, Yoshimura Y, Nakaguchi T, Haneishi H, Oda S.
PMID: 31481115
Crit Care. 2019 Sep 03;23(1):295. doi: 10.1186/s13054-019-2570-y.

No abstract available.

Cite
Shinozaki M, Nakada TA, Kawaguchi R, et al. Feedback function for capillary refilling time measurement device. Crit Care. 2019;23(1):295doi: 10.1186/s13054-019-2570-y.
Shinozaki, M., Nakada, T. A., Kawaguchi, R., Yoshimura, Y., Nakaguchi, T., Haneishi, H., & Oda, S. (2019). Feedback function for capillary refilling time measurement device. Critical care (London, England), 23(1), 295. https://doi.org/10.1186/s13054-019-2570-y
Shinozaki, Masayoshi, et al. "Feedback function for capillary refilling time measurement device." Critical care (London, England) vol. 23,1 (2019): 295. doi: https://doi.org/10.1186/s13054-019-2570-y
Shinozaki M, Nakada TA, Kawaguchi R, Yoshimura Y, Nakaguchi T, Haneishi H, Oda S. Feedback function for capillary refilling time measurement device. Crit Care. 2019 Sep 03;23(1):295. doi: 10.1186/s13054-019-2570-y. PMID: 31481115; PMCID: PMC6724324.
Copy Download .nbib Format: NLM
Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin.

Clinical case reports

Yoshioka K, Tateishi C, Kato H, Chen KR.
PMID: 30455888
Clin Case Rep. 2018 Sep 12;6(11):2045-2047. doi: 10.1002/ccr3.1803. eCollection 2018 Nov.

We reported a patient with systemic lupus erythematosus complicated by livedoid vasculopathy (LV), who responded well to intravenous immunoglobulin and warfarin. Cutaneous lesions of LV resemble those of cutaneous vasculitis. LV should be included in the differential diagnosis of...

Cite
Yoshioka K, Tateishi C, Kato H, et al. Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin. Clin Case Rep. 2018;6(11):2045-2047doi: 10.1002/ccr3.1803.
Yoshioka, K., Tateishi, C., Kato, H., & Chen, K. R. (2018). Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin. Clinical case reports, 6(11), 2045-2047. https://doi.org/10.1002/ccr3.1803
Yoshioka, Katsunobu, et al. "Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin." Clinical case reports vol. 6,11 (2018): 2045-2047. doi: https://doi.org/10.1002/ccr3.1803
Yoshioka K, Tateishi C, Kato H, Chen KR. Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin. Clin Case Rep. 2018 Sep 12;6(11):2045-2047. doi: 10.1002/ccr3.1803. eCollection 2018 Nov. PMID: 30455888; PMCID: PMC6230605.
Copy Download .nbib Format: NLM
Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure.

Open heart

Sato Y, Yoshihisa A, Kanno Y, Watanabe S, Yokokawa T, Abe S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Saitoh SI, Takeishi Y.
PMID: 28674631
Open Heart. 2017 Apr 28;4(1):e000598. doi: 10.1136/openhrt-2017-000598. eCollection 2017.

OBJECTIVE: Liver dysfunction due to heart failure (HF) is known as congestive hepatopathy. It has recently been reported that liver stiffness assessed by transient elastography reflects increased central venous pressure. The Fibrosis-4 (FIB4) index (age (years) × aspartate aminotransferase...

Cite
Sato Y, Yoshihisa A, Kanno Y, et al. Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure. Open Heart. 2017;4(1):e000598doi: 10.1136/openhrt-2017-000598.
Sato, Y., Yoshihisa, A., Kanno, Y., Watanabe, S., Yokokawa, T., Abe, S., Misaka, T., Sato, T., Suzuki, S., Oikawa, M., Kobayashi, A., Yamaki, T., Kunii, H., Nakazato, K., Saitoh, S. I., & Takeishi, Y. (2017). Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure. Open heart, 4(1), e000598. https://doi.org/10.1136/openhrt-2017-000598
Sato, Yu, et al. "Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure." Open heart vol. 4,1 (2017): e000598. doi: https://doi.org/10.1136/openhrt-2017-000598
Sato Y, Yoshihisa A, Kanno Y, Watanabe S, Yokokawa T, Abe S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Saitoh SI, Takeishi Y. Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure. Open Heart. 2017 Apr 28;4(1):e000598. doi: 10.1136/openhrt-2017-000598. eCollection 2017. PMID: 28674631; PMCID: PMC5471867.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 617 entries